Buscar
Mostrando ítems 31-40 de 529
ALLOGENEIC TRANSPLANTATION WITH BLOOD STEM-CELLS MOBILIZED BY RHG-CSF FOR HEMATOLOGICAL MALIGNANCIES
(Stockton PressBasingstokeInglaterra, 1995)
Role of NFKB2 on the early myeloid differentiation of CD34+ hematopoietic stem/progenitor cells
(ELSEVIER SCI LTD, 2010)
To better understand the early events regulating lineage-specific hematopoietic differentiation, we analyzed the transcriptional profiles of CD34+ human hematopoietic stem and progenitor cells (HSPCs) subjected to ...
Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment
(Elsevier B.V., 2008-01-01)
Objective. Based on the recognition that marrow contains progenitors for bone as well as blood, we undertook the first trial of bone marrow transplantation (BMT) for a genetic disorder of bone, osteogenesis imperfecta. ...
The Antidiabetic Effect of MSCs is not Impaired by Insulin Prophylaxis and is not Improved by a Second Dose of Cells
(2011)
Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal cells (MSCs) allows ...
The Antidiabetic Effect of MSCs is not Impaired by Insulin Prophylaxis and is not Improved by a Second Dose of Cells
(2011)
Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal cells (MSCs) allows ...
Factors affecting hematopoietic progenitor cell mobilization: An analysis of 307 patients
(PERGAMON-ELSEVIER SCIENCE LTD, 2008)
We reviewed the data of 307 patients treated with autologous bone marrow transplantation with the aim to identify factors associated with poor hematopoietic stern cell (HSC) mobilization after administration of cyclophosphamide ...